1227494-24-7 Usage
Uses
Used in Organic Synthesis:
2-(3-phenylpyridin-2-yl)acetonitrile is utilized as a key intermediate in organic synthesis for the creation of a range of biologically active molecules. Its unique structure allows for the development of new organic compounds with potential applications across different industries.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-(3-phenylpyridin-2-yl)acetonitrile serves as a crucial building block for the preparation of potential drugs and pharmaceutical products. Its chemical properties contribute to the design and synthesis of novel therapeutic agents.
Used in Material Science:
2-(3-phenylpyridin-2-yl)acetonitrile may also find applications in material science, where its structural attributes could be leveraged to develop new materials with specific properties for various uses.
Used as a Ligand in Coordination Chemistry:
Furthermore, 2-(3-phenylpyridin-2-yl)acetonitrile has potential as a ligand in coordination chemistry, where it can be used to form complexes with metal ions, potentially leading to new catalysts or materials with unique electronic and coordination properties.
Check Digit Verification of cas no
The CAS Registry Mumber 1227494-24-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,7,4,9 and 4 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1227494-24:
(9*1)+(8*2)+(7*2)+(6*7)+(5*4)+(4*9)+(3*4)+(2*2)+(1*4)=157
157 % 10 = 7
So 1227494-24-7 is a valid CAS Registry Number.
1227494-24-7Relevant articles and documents
PYRIMIDONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE
-
Paragraph 0677-0679, (2014/07/22)
The present invention relates to a compound having the general formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, codrug, cocrystal, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, which are useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.
